site stats

Syrs investor relations

WebSyros Pharmaceuticals (SYRS) NASDAQ: SYRS. Stock Analysis Analyst Forecasts Technical Analysis Chart Earnings Dividends Financials Insider Trading Crowd Wisdom Hedge … WebNov 14, 2024 · Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ET Company Participants Karen Hunady - Director-Corporate Communications & Investor Relations

Syros Pharmaceuticals, Inc. Common Stock (SYRS)

WebSYRS Dividend History Back to SYRS Overview The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Our... WebApr 6, 2024 · A high-level overview of Syros Pharmaceuticals, Inc. (SYRS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment … himmeli pori https://ambertownsendpresents.com

SYRS Stock Price Syros Pharmaceuticals Inc. Stock Quote ... - MarketWatch

WebMar 7, 2024 · Investor Relations Syros Pharmaceuticals Inc SYRS Chart Morningstar Rating Rating as of Mar 7, 2024 Quote Chart Stock Analysis News Price vs Fair Value Sustainability ... WebHeadquarters. 35 CambridgePark Drive 4th Floor Cambridge, MA 02140 Tel: (617) 744-1340 WebApr 12, 2024 · How much institutional selling is happening at Syros Pharmaceuticals? Institutional investors have sold a total of 22,154,450 shares in the last 24 months. This volume of shares sold represents approximately $390.15M in transactions. This page (NASDAQ:SYRS) was last updated on 4/3/2024 by MarketBeat.com Staff. himmelitie 7

Syros Pharmaceuticals, Inc. (SYRS) Q3 2024 Earnings Call …

Category:Syros Pharmaceuticals, Inc. (SYRS) Q3 2024 Earnings Call …

Tags:Syrs investor relations

Syrs investor relations

SYRS Syros Pharmaceuticals Inc. Stock Price & News - WSJ

WebFind the latest Syros Pharmaceuticals, Inc. (SYRS) stock quote, history, news and other vital information to help you with your stock trading and investing.

Syrs investor relations

Did you know?

WebMar 8, 2024 · Investor Relations Syros Pharmaceuticals Inc SYRS Financial Information Morningstar Rating Rating as of Mar 8, 2024 Quote Chart Stock Analysis News Price vs Fair Value ... WebApr 7, 2024 · Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of …

WebDec 16, 2024 · What does smart money think about Syros Pharmaceuticals, Inc. (NASDAQ:SYRS)? At Q3's end, a total of 9 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of ... WebDec 30, 2024 · 3,358,069. 436,214. 7.698215. Back to SYRS Overview. NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid ...

WebSYRS Complete Syros Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebApr 10, 2024 · Syros Pharmaceuticals, Inc. (SYRS) Reports Q4 Loss, Lags Revenue Estimates. Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises …

WebSep 15, 2024 · Syros’ Investor Contact: Hannah Deresiewicz Stern Investor Relations, Inc. 212-362-1200 [email protected] Tyme’s Investor Contact …

WebMar 6, 2024 · This call is being webcast live on the Investors and Media section of Syros’ website […] Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2024 Earnings Call Transcript March 2, 2024 Operator: Good ... him kissWebDec 13, 2024 · The image below, which you can click on for greater detail, shows that at September 2024 Syros Pharmaceuticals had debt of US$40.1m, up from US$19.7m in one year. However, it does have US$145.6m ... himmeli ohjeetWebOct 14, 2024 · Find the latest SEC Filings data for Syros Pharmaceuticals, Inc. Common Stock (SYRS) at Nasdaq.com. Syros Pharmaceuticals, Inc. Common Stock (SYRS) SEC … himmelitarvikkeetWebSep 15, 2024 · Following the closing of the Merger, the combined company will trade on The Nasdaq Global Select Market under the ticker symbol “SYRS,” and will be led by Syros’ existing management team ... himmelisWebAug 9, 2024 · CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today reported financial results for the quarter ended June 30, 2024 and provided a corporate update. ... Stern Investor Relations, Inc. 212-362-1200 … himmelkampenWebOct 18, 2024 · About Syros Pharmaceuticals, Inc. 35 CAMBRIDGEPARK DRIVE 4TH FLOOR, CAMBRIDGE, Massachusetts, 2140, United States +1 617 744-1340 … himmelin teko ohjeWebFeb 24, 2024 · Investor Relations Syros Pharmaceuticals Inc SYRS Sustainability Morningstar Rating Rating as of Nov 22, 2024. Quote Chart Stock Analysis News Price vs Fair Value ... himmel jacket